Rachel F. Eyler

Risk Factors for Systemic Vancomycin Exposure Following Administration of Oral Vancomycin for the Treatment of <i>Clostridium difficile</i> Infection

Natasha N. Pettit, Daryl D. DePestel, Alexander L. Fohl et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2015 · 46 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +14

Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms

Jian Shi, Xinwen Wang, Rachel F. Eyler et al. · Basic & Clinical Pharmacology & Toxicology · 2016 · 43 citations · Full text

Life Sciences, Biochemistry, Genetics +14

Defining Dunes: Evaluating How Dune Feature Definitions Affect Dune Interpretations from Remote Sensing

Stephanie Thompson, Phillipe A. Wernette, Rachel F. Eyler et al. · Journal of Coastal Research · 2018 · 41 citations · Full text

Natural Sciences, Earth Sciences, Geography +17

Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions

Wendy L. St. Peter, Andrew S. Bzowyckyj, Tracy Anderson-Haag et al. · American Journal of Health-System Pharmacy · 2024 · 41 citations · Full text

Medicine, Clinical Pharmacy, Nephrology +17

Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Critically <scp>I</scp> ll Patients Receiving Continuous Venovenous Hemodialysis and/or Extracorporeal Membrane Oxygenation

Rachel F. Eyler, Michael Heung, Melissa Pleva et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2012 · 39 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15